Canada markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
14.30-0.01 (-0.07%)
At close: 04:00PM EDT
14.35 +0.05 (+0.35%)
After hours: 06:40PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 45.40B
Enterprise Value 76.49B
Trailing P/E 45.40
Forward P/E 17.09
PEG Ratio (5 yr expected) 0.71
Price/Sales (ttm)1.53
Price/Book (mrq)0.87
Enterprise Value/Revenue 2.58
Enterprise Value/EBITDA 12.33

Trading Information

Stock Price History

Beta (5Y Monthly) 0.50
52-Week Change 3-4.92%
S&P500 52-Week Change 332.96%
52 Week High 315.08
52 Week Low 312.58
50-Day Moving Average 314.55
200-Day Moving Average 314.00

Share Statistics

Avg Vol (3 month) 32.26M
Avg Vol (10 day) 31.9M
Shares Outstanding 53.17B
Implied Shares Outstanding 63.17B
Float 81.55B
% Held by Insiders 10.01%
% Held by Institutions 12.31%
Shares Short (Sept 30, 2024) 48.42M
Short Ratio (Sept 30, 2024) 44.7
Short % of Float (Sept 30, 2024) 40.27%
Short % of Shares Outstanding (Sept 30, 2024) 40.27%
Shares Short (prior month Aug 30, 2024) 48.23M

Dividends & Splits

Forward Annual Dividend Rate 40.58
Forward Annual Dividend Yield 44.09%
Trailing Annual Dividend Rate 3188.00
Trailing Annual Dividend Yield 31,313.77%
5 Year Average Dividend Yield 44.70
Payout Ratio 4195.55%
Dividend Date 3Jul 08, 2024
Ex-Dividend Date 4Mar 27, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 3.40%
Operating Margin (ttm)15.92%

Management Effectiveness

Return on Assets (ttm)2.05%
Return on Equity (ttm)2.04%

Income Statement

Revenue (ttm)4.41T
Revenue Per Share (ttm)1,407.18
Quarterly Revenue Growth (yoy)14.10%
Gross Profit (ttm)N/A
EBITDA 1.17T
Net Income Avi to Common (ttm)149.92B
Diluted EPS (ttm)0.31
Quarterly Earnings Growth (yoy)6.50%

Balance Sheet

Total Cash (mrq)804.27B
Total Cash Per Share (mrq)512.58
Total Debt (mrq)6.1T
Total Debt/Equity (mrq)78.18%
Current Ratio (mrq)1.26
Book Value Per Share (mrq)4,970.05

Cash Flow Statement

Operating Cash Flow (ttm)794.25B
Levered Free Cash Flow (ttm)510.87B